These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 25801501)

  • 21. Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence.
    Jayaram-Lindström N; Konstenius M; Eksborg S; Beck O; Hammarberg A; Franck J
    Neuropsychopharmacology; 2008 Jul; 33(8):1856-63. PubMed ID: 17957221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.
    Newton TF; Roache JD; De La Garza R; Fong T; Wallace CL; Li SH; Elkashef A; Chiang N; Kahn R
    Neuropsychopharmacology; 2006 Jul; 31(7):1537-44. PubMed ID: 16319910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study.
    Worley MJ; Swanson A-N; Heinzerling KG; Roche DJ; Shoptaw S
    Drug Alcohol Depend; 2016 May; 162():245-50. PubMed ID: 26993372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers.
    Haney M; Ramesh D; Glass A; Pavlicova M; Bedi G; Cooper ZD
    Neuropsychopharmacology; 2015 Oct; 40(11):2489-98. PubMed ID: 25881117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder.
    Karl D; Bumb JM; Bach P; Dinter C; Koopmann A; Hermann D; Mann K; Kiefer F; Vollstädt-Klein S
    Psychopharmacology (Berl); 2021 Aug; 238(8):2179-2189. PubMed ID: 33846866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder.
    Shi Z; Wang AL; Jagannathan K; Fairchild VP; O'Brien CP; Childress AR; Langleben DD
    J Psychiatry Neurosci; 2018 Jul; 43(4):254-261. PubMed ID: 29947607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment.
    Hyman SM; Fox H; Hong KI; Doebrick C; Sinha R
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):134-43. PubMed ID: 17469937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine's subjective and reinforcing effects.
    Johnson BA; Roache JD; Ait-Daoud N; Wallace C; Wells L; Dawes M; Wang Y
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):203-13. PubMed ID: 15850499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute exercise ameliorates craving and inhibitory deficits in methamphetamine: An ERP study.
    Wang D; Zhou C; Chang YK
    Physiol Behav; 2015 Aug; 147():38-46. PubMed ID: 25846839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness.
    Krupitsky E; Nunes EV; Ling W; Gastfriend DR; Memisoglu A; Silverman BL
    Addiction; 2013 Sep; 108(9):1628-37. PubMed ID: 23701526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomized trial].
    Krupitskiĭ EM; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Blokhina EA; Silverman BL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5 Pt 2):3-11. PubMed ID: 22951790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of naltrexone on cue-elicited craving among hazardous drinkers: the moderational role of positive outcome expectancies.
    Palfai T; Davidson D; Swift R
    Exp Clin Psychopharmacol; 1999 Aug; 7(3):266-73. PubMed ID: 10472515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.
    Newton TF; Reid MS; De La Garza R; Mahoney JJ; Abad A; Condos R; Palamar J; Halkitis PN; Mojisak J; Anderson A; Li SH; Elkashef A
    Int J Neuropsychopharmacol; 2008 Dec; 11(8):1037-45. PubMed ID: 18664303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial.
    Miranda R; Ray L; Blanchard A; Reynolds EK; Monti PM; Chun T; Justus A; Swift RM; Tidey J; Gwaltney CJ; Ramirez J
    Addict Biol; 2014 Sep; 19(5):941-54. PubMed ID: 23489253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
    Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH;
    Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic moderators of naltrexone's effects on alcohol cue reactivity.
    McGeary JE; Monti PM; Rohsenow DJ; Tidey J; Swift R; Miranda R
    Alcohol Clin Exp Res; 2006 Aug; 30(8):1288-96. PubMed ID: 16899031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naltrexone's effect on cue-elicited craving among alcoholics in treatment.
    Monti PM; Rohsenow DJ; Hutchison KE; Swift RM; Mueller TI; Colby SM; Brown RA; Gulliver SB; Gordon A; Abrams DB
    Alcohol Clin Exp Res; 1999 Aug; 23(8):1386-94. PubMed ID: 10470982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial.
    Schmitz JM; Stotts AL; Yoon JH; Northrup TF; Villarreal YR; Yammine L; Weaver MF; Carmody T; Shoptaw S; Trivedi MH
    J Subst Use Addict Treat; 2023 Aug; 151():208987. PubMed ID: 36822269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naltrexone alters the processing of social and emotional stimuli in healthy adults.
    Wardle MC; Bershad AK; de Wit H
    Soc Neurosci; 2016 Dec; 11(6):579-91. PubMed ID: 26710657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.
    Mousavi SG; Sharbafchi MR; Salehi M; Peykanpour M; Karimian Sichani N; Maracy M
    Arch Iran Med; 2015 Jan; 18(1):28-33. PubMed ID: 25556383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.